查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1867599

靜脈灌註注射器：全球市場佔有率和排名、總收入和需求預測（2025-2031年）

IV Flush Syringe - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 126 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2024 年全球靜脈灌註注射器市場規模估計為 5.79 億美元，預計到 2031 年將成長至 9.29 億美元，2025 年至 2031 年的複合年成長率為 7.0%。

本報告對近期關稅調整和國際策略反制措施對靜脈沖洗注射器跨境產業佈局、資本配置模式、區域經濟相互依存關係和供應鏈重組的影響進行了全面評估。

靜脈沖洗注射器是無菌的拋棄式醫療耗材，旨在維持靜脈通路裝置的通暢性並減少導管相關併發症。無論是預填充式注射器或根據通訊協定在照護端配製的注射器，這些注射器都能輸送標準化的沖洗液，用於清潔留置導管、預防血栓症並降低感染風險。本產品的主要特性包括無菌包裝、標準化劑量和易用性。這些特性最大限度地降低了配製和給藥過程中的污染風險，同時最佳化了臨床工作流程。隨著感染預防和輸液安全成為核心品質指標，靜脈沖洗注射器正從常規耗材發展成為策略性的臨床安全工具，並被納入標準化護理路徑和醫院採購優先事項。 2024年，全球靜脈沖洗注射器的產量將達到約10.53億支，全球平均市場價格約為每支0.55美元。

監管機構日益重視感染預防和輸液安全，推動醫療機構在其臨床通訊協定和採購框架中採用一次性預填充標準化沖洗液。這些政策因素正在系統性地創造對靜脈沖洗注射器的需求。同時，醫院為提高護理效率、縮短配製時間並最大限度地減少人為錯誤，正在加速從手工配製向市售標準化產品的過渡。主要醫療設備和耗材製造商在其投資者溝通和年度報告中，將預預填充沖洗液產能擴張和產品創新列為策略重點，從而推動了生產、供應鏈和商業化能力的快速提升。標準化的包裝和可追溯性，以及與電子庫存管理系統的整合，使採購者更容易在合規性和成本之間取得平衡，從而促進永續的需求。

高品質的無菌生產和穩定的供應是核心挑戰。預填充產品需要符合GMP標準的灌裝能力和穩健的供應鏈，這需要大量的資金和營運投入，一旦發生供應衝擊，供應商將面臨風險。不同司法管轄區的監管差異使跨境部署更加複雜，並增加了認證負擔。臨床對材料相容性、溶液穩定性和易用包裝的要求，需要持續的研發和嚴格的品管。最後，如果產品無法與醫院資訊系統和庫存工作流程無縫整合，可能會延緩臨床應用並降低客戶維繫。

下游採購正從零散的耗材採購轉向整合化、流程導向的解決方案。醫院越來越注重產品的合規性、易用性和系統互通性，同時培訓、監控和品質保證服務也納入採購決策的考量。針對特定場景的產品規格，例如兒科用小容量注射器、化療最佳化模型以及用於封閉系統的帶蓋注射器，正變得越來越受歡迎。製造商透過擴展產品系列（例如，顏色編碼的瓶蓋、可追溯的條碼）並提供實施支援服務來提升客戶價值，從而推動下游對高品質、高利潤產品的需求。

本報告旨在按地區/國家、類型和應用對全球靜脈沖洗注射器市場進行全面分析，重點關注總銷售量、收入、價格、市場佔有率和主要企業的排名。

本報告以銷售量（千支）和收入（百萬美元）為單位，對靜脈沖洗注射器市場規模、估算和預測進行了呈現，基準年為2024年，並涵蓋了2020年至2031年的歷史數據和預測數據。報告提供定量和定性分析，旨在幫助讀者制定業務和成長策略，評估市場競爭，分析自身在當前市場中的地位，並就靜脈沖洗注射器市場做出明智的商業決策。

市場區隔

公司

  • BD
  • Medline
  • Medefil
  • B. Braun
  • Cardinal Health
  • Weigao Group
  • Jiangsu Impex Technology
  • Fuzhou Haiwang Fuyao Pharmaceutical Co., Ltd.
  • Shandong Zhongbaokang
  • Nam Kwang Chemical Pharmaceuticals
  • Guangdong Aixide Pharmaceutical Co., Ltd.
  • Guerbet
  • Sterisets
  • Aquabiliti

按類型分類的細分市場

  • 生理食鹽水食鹽水靜脈沖洗注射器
  • 肝素靜脈沖洗注射器

應用領域

  • 醫院
  • 診所
  • 其他

按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 韓國
    • 東南亞
    • 印度
    • 澳洲
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 荷蘭
    • 北歐國家
    • 其他歐洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中東和非洲
    • 土耳其
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他中東和非洲地區

The global market for IV Flush Syringe was estimated to be worth US$ 579 million in 2024 and is forecast to a readjusted size of US$ 929 million by 2031 with a CAGR of 7.0% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on IV Flush Syringe cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

An IV Flush Syringe is a sterile, single-use medical consumable designed to maintain the patency of venous access devices and reduce catheter-related complications. Whether provided as prefilled syringes or prepared at point-of-care per protocol, these syringes deliver standardized flush solutions to clear indwelling catheters, help prevent thrombosis, and lower infection risk. Key product attributes include sterile packaging, dose standardization, and ease of use-features that minimize contamination opportunities during preparation and administration while improving clinical workflow. As infection prevention and infusion safety have become central quality metrics, IV flush syringes are evolving from routine consumables into strategic clinical-safety tools integrated into standardized care pathways and hospital procurement priorities.In 2024, global IV Flush Syringe production reached approximately 1053 m units, with an average global market price of around US$ 0.55 perunit

Heightened regulatory emphasis on infection prevention and infusion safety is prompting healthcare providers to adopt single-use, prefilled, or standardized flush solutions within clinical protocols and procurement frameworks. These policy drivers create institutional demand for IV flush syringes. At the same time, hospitals' need to improve nursing efficiency, reduce preparation time, and minimize human error is accelerating the shift from manual preparation to commercially supplied, standardized products. Leading medtech and consumables companies have signalled in investor communications and annual reports that capacity expansion and product innovation in prefilled flush solutions are priority strategic initiatives-fostering rapid advances in manufacturing, supply chain, and commercialization capabilities. Integration of standardized packaging and traceability with electronic inventory systems further enables buyers to balance compliance and cost, enlarging sustainable demand.

High-quality sterile manufacturing and reliable supply are core challenges: prefilled solutions demand GMP-level filling capacity and resilient supply chains, requiring substantial capital and operational commitment and exposing suppliers to risk during supply shocks. Regulatory heterogeneity across jurisdictions complicates cross-border launches and adds to certification burdens. Clinical expectations around material compatibility, solution stability, and user-friendly packaging necessitate continuous R&D and rigorous quality control. Finally, failure to seamlessly integrate products with hospital information systems and inventory workflows can slow clinical adoption and reduce customer retention.

Downstream procurement is moving from ad-hoc consumable purchases toward integrated, process-oriented solutions: hospitals increasingly evaluate products based on regulatory credentials, ease of use, and system interoperability, while training, monitoring, and quality assurance services are becoming part of purchasing decisions. Scenario-specific formats-such as small-volume pediatric syringes, chemo-optimized variants, and syringes with closed-system caps-are gaining preference. Manufacturers are enhancing customer value by extending product portfolios (e.g., color-coded caps, traceable barcodes) and offering enablement services, which elevates downstream demand toward higher quality and higher-margin offerings.

This report aims to provide a comprehensive presentation of the global market for IV Flush Syringe, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of IV Flush Syringe by region & country, by Type, and by Application.

The IV Flush Syringe market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding IV Flush Syringe.

Market Segmentation

By Company

  • BD
  • Medline
  • Medefil
  • B. Braun
  • Cardinal Health
  • Weigao Group
  • Jiangsu Impex Technology
  • Fuzhou Haiwang Fuyao Pharmaceutical Co., Ltd.
  • Shandong Zhongbaokang
  • Nam Kwang Chemical Pharmaceuticals
  • Guangdong Aixide Pharmaceutical Co., Ltd.
  • Guerbet
  • Sterisets
  • Aquabiliti

Segment by Type

  • Saline IV Flush Syringe
  • Heparin IV Flush Syringe

Segment by Application

  • Hospital
  • Clinic
  • Others

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of IV Flush Syringe manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of IV Flush Syringe in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of IV Flush Syringe in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 IV Flush Syringe Product Introduction
  • 1.2 Global IV Flush Syringe Market Size Forecast
    • 1.2.1 Global IV Flush Syringe Sales Value (2020-2031)
    • 1.2.2 Global IV Flush Syringe Sales Volume (2020-2031)
    • 1.2.3 Global IV Flush Syringe Sales Price (2020-2031)
  • 1.3 IV Flush Syringe Market Trends & Drivers
    • 1.3.1 IV Flush Syringe Industry Trends
    • 1.3.2 IV Flush Syringe Market Drivers & Opportunity
    • 1.3.3 IV Flush Syringe Market Challenges
    • 1.3.4 IV Flush Syringe Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global IV Flush Syringe Players Revenue Ranking (2024)
  • 2.2 Global IV Flush Syringe Revenue by Company (2020-2025)
  • 2.3 Global IV Flush Syringe Players Sales Volume Ranking (2024)
  • 2.4 Global IV Flush Syringe Sales Volume by Company Players (2020-2025)
  • 2.5 Global IV Flush Syringe Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers IV Flush Syringe Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers IV Flush Syringe Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of IV Flush Syringe
  • 2.9 IV Flush Syringe Market Competitive Analysis
    • 2.9.1 IV Flush Syringe Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by IV Flush Syringe Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IV Flush Syringe as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Saline IV Flush Syringe
    • 3.1.2 Heparin IV Flush Syringe
  • 3.2 Global IV Flush Syringe Sales Value by Type
    • 3.2.1 Global IV Flush Syringe Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global IV Flush Syringe Sales Value, by Type (2020-2031)
    • 3.2.3 Global IV Flush Syringe Sales Value, by Type (%) (2020-2031)
  • 3.3 Global IV Flush Syringe Sales Volume by Type
    • 3.3.1 Global IV Flush Syringe Sales Volume by Type (2020 VS 2024 VS 2031)
    • 3.3.2 Global IV Flush Syringe Sales Volume, by Type (2020-2031)
    • 3.3.3 Global IV Flush Syringe Sales Volume, by Type (%) (2020-2031)
  • 3.4 Global IV Flush Syringe Average Price by Type (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Hospital
    • 4.1.2 Clinic
    • 4.1.3 Others
  • 4.2 Global IV Flush Syringe Sales Value by Application
    • 4.2.1 Global IV Flush Syringe Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global IV Flush Syringe Sales Value, by Application (2020-2031)
    • 4.2.3 Global IV Flush Syringe Sales Value, by Application (%) (2020-2031)
  • 4.3 Global IV Flush Syringe Sales Volume by Application
    • 4.3.1 Global IV Flush Syringe Sales Volume by Application (2020 VS 2024 VS 2031)
    • 4.3.2 Global IV Flush Syringe Sales Volume, by Application (2020-2031)
    • 4.3.3 Global IV Flush Syringe Sales Volume, by Application (%) (2020-2031)
  • 4.4 Global IV Flush Syringe Average Price by Application (2020-2031)

5 Segmentation by Region

  • 5.1 Global IV Flush Syringe Sales Value by Region
    • 5.1.1 Global IV Flush Syringe Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global IV Flush Syringe Sales Value by Region (2020-2025)
    • 5.1.3 Global IV Flush Syringe Sales Value by Region (2026-2031)
    • 5.1.4 Global IV Flush Syringe Sales Value by Region (%), (2020-2031)
  • 5.2 Global IV Flush Syringe Sales Volume by Region
    • 5.2.1 Global IV Flush Syringe Sales Volume by Region: 2020 VS 2024 VS 2031
    • 5.2.2 Global IV Flush Syringe Sales Volume by Region (2020-2025)
    • 5.2.3 Global IV Flush Syringe Sales Volume by Region (2026-2031)
    • 5.2.4 Global IV Flush Syringe Sales Volume by Region (%), (2020-2031)
  • 5.3 Global IV Flush Syringe Average Price by Region (2020-2031)
  • 5.4 North America
    • 5.4.1 North America IV Flush Syringe Sales Value, 2020-2031
    • 5.4.2 North America IV Flush Syringe Sales Value by Country (%), 2024 VS 2031
  • 5.5 Europe
    • 5.5.1 Europe IV Flush Syringe Sales Value, 2020-2031
    • 5.5.2 Europe IV Flush Syringe Sales Value by Country (%), 2024 VS 2031
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific IV Flush Syringe Sales Value, 2020-2031
    • 5.6.2 Asia Pacific IV Flush Syringe Sales Value by Region (%), 2024 VS 2031
  • 5.7 South America
    • 5.7.1 South America IV Flush Syringe Sales Value, 2020-2031
    • 5.7.2 South America IV Flush Syringe Sales Value by Country (%), 2024 VS 2031
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa IV Flush Syringe Sales Value, 2020-2031
    • 5.8.2 Middle East & Africa IV Flush Syringe Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions IV Flush Syringe Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions IV Flush Syringe Sales Value and Sales Volume
    • 6.2.1 Key Countries/Regions IV Flush Syringe Sales Value, 2020-2031
    • 6.2.2 Key Countries/Regions IV Flush Syringe Sales Volume, 2020-2031
  • 6.3 United States
    • 6.3.1 United States IV Flush Syringe Sales Value, 2020-2031
    • 6.3.2 United States IV Flush Syringe Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States IV Flush Syringe Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe IV Flush Syringe Sales Value, 2020-2031
    • 6.4.2 Europe IV Flush Syringe Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe IV Flush Syringe Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China IV Flush Syringe Sales Value, 2020-2031
    • 6.5.2 China IV Flush Syringe Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China IV Flush Syringe Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan IV Flush Syringe Sales Value, 2020-2031
    • 6.6.2 Japan IV Flush Syringe Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan IV Flush Syringe Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea IV Flush Syringe Sales Value, 2020-2031
    • 6.7.2 South Korea IV Flush Syringe Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea IV Flush Syringe Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia IV Flush Syringe Sales Value, 2020-2031
    • 6.8.2 Southeast Asia IV Flush Syringe Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia IV Flush Syringe Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India IV Flush Syringe Sales Value, 2020-2031
    • 6.9.2 India IV Flush Syringe Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India IV Flush Syringe Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 BD
    • 7.1.1 BD Company Information
    • 7.1.2 BD Introduction and Business Overview
    • 7.1.3 BD IV Flush Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.1.4 BD IV Flush Syringe Product Offerings
    • 7.1.5 BD Recent Development
  • 7.2 Medline
    • 7.2.1 Medline Company Information
    • 7.2.2 Medline Introduction and Business Overview
    • 7.2.3 Medline IV Flush Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.2.4 Medline IV Flush Syringe Product Offerings
    • 7.2.5 Medline Recent Development
  • 7.3 Medefil
    • 7.3.1 Medefil Company Information
    • 7.3.2 Medefil Introduction and Business Overview
    • 7.3.3 Medefil IV Flush Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.3.4 Medefil IV Flush Syringe Product Offerings
    • 7.3.5 Medefil Recent Development
  • 7.4 B. Braun
    • 7.4.1 B. Braun Company Information
    • 7.4.2 B. Braun Introduction and Business Overview
    • 7.4.3 B. Braun IV Flush Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.4.4 B. Braun IV Flush Syringe Product Offerings
    • 7.4.5 B. Braun Recent Development
  • 7.5 Cardinal Health
    • 7.5.1 Cardinal Health Company Information
    • 7.5.2 Cardinal Health Introduction and Business Overview
    • 7.5.3 Cardinal Health IV Flush Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.5.4 Cardinal Health IV Flush Syringe Product Offerings
    • 7.5.5 Cardinal Health Recent Development
  • 7.6 Weigao Group
    • 7.6.1 Weigao Group Company Information
    • 7.6.2 Weigao Group Introduction and Business Overview
    • 7.6.3 Weigao Group IV Flush Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.6.4 Weigao Group IV Flush Syringe Product Offerings
    • 7.6.5 Weigao Group Recent Development
  • 7.7 Jiangsu Impex Technology
    • 7.7.1 Jiangsu Impex Technology Company Information
    • 7.7.2 Jiangsu Impex Technology Introduction and Business Overview
    • 7.7.3 Jiangsu Impex Technology IV Flush Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.7.4 Jiangsu Impex Technology IV Flush Syringe Product Offerings
    • 7.7.5 Jiangsu Impex Technology Recent Development
  • 7.8 Fuzhou Haiwang Fuyao Pharmaceutical Co., Ltd.
    • 7.8.1 Fuzhou Haiwang Fuyao Pharmaceutical Co., Ltd. Company Information
    • 7.8.2 Fuzhou Haiwang Fuyao Pharmaceutical Co., Ltd. Introduction and Business Overview
    • 7.8.3 Fuzhou Haiwang Fuyao Pharmaceutical Co., Ltd. IV Flush Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.8.4 Fuzhou Haiwang Fuyao Pharmaceutical Co., Ltd. IV Flush Syringe Product Offerings
    • 7.8.5 Fuzhou Haiwang Fuyao Pharmaceutical Co., Ltd. Recent Development
  • 7.9 Shandong Zhongbaokang
    • 7.9.1 Shandong Zhongbaokang Company Information
    • 7.9.2 Shandong Zhongbaokang Introduction and Business Overview
    • 7.9.3 Shandong Zhongbaokang IV Flush Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.9.4 Shandong Zhongbaokang IV Flush Syringe Product Offerings
    • 7.9.5 Shandong Zhongbaokang Recent Development
  • 7.10 Nam Kwang Chemical Pharmaceuticals
    • 7.10.1 Nam Kwang Chemical Pharmaceuticals Company Information
    • 7.10.2 Nam Kwang Chemical Pharmaceuticals Introduction and Business Overview
    • 7.10.3 Nam Kwang Chemical Pharmaceuticals IV Flush Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.10.4 Nam Kwang Chemical Pharmaceuticals IV Flush Syringe Product Offerings
    • 7.10.5 Nam Kwang Chemical Pharmaceuticals Recent Development
  • 7.11 Guangdong Aixide Pharmaceutical Co., Ltd.
    • 7.11.1 Guangdong Aixide Pharmaceutical Co., Ltd. Company Information
    • 7.11.2 Guangdong Aixide Pharmaceutical Co., Ltd. Introduction and Business Overview
    • 7.11.3 Guangdong Aixide Pharmaceutical Co., Ltd. IV Flush Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.11.4 Guangdong Aixide Pharmaceutical Co., Ltd. IV Flush Syringe Product Offerings
    • 7.11.5 Guangdong Aixide Pharmaceutical Co., Ltd. Recent Development
  • 7.12 Guerbet
    • 7.12.1 Guerbet Company Information
    • 7.12.2 Guerbet Introduction and Business Overview
    • 7.12.3 Guerbet IV Flush Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.12.4 Guerbet IV Flush Syringe Product Offerings
    • 7.12.5 Guerbet Recent Development
  • 7.13 Sterisets
    • 7.13.1 Sterisets Company Information
    • 7.13.2 Sterisets Introduction and Business Overview
    • 7.13.3 Sterisets IV Flush Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.13.4 Sterisets IV Flush Syringe Product Offerings
    • 7.13.5 Sterisets Recent Development
  • 7.14 Aquabiliti
    • 7.14.1 Aquabiliti Company Information
    • 7.14.2 Aquabiliti Introduction and Business Overview
    • 7.14.3 Aquabiliti IV Flush Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.14.4 Aquabiliti IV Flush Syringe Product Offerings
    • 7.14.5 Aquabiliti Recent Development

8 Industry Chain Analysis

  • 8.1 IV Flush Syringe Industrial Chain
  • 8.2 IV Flush Syringe Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 IV Flush Syringe Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 IV Flush Syringe Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. IV Flush Syringe Market Trends
  • Table 2. IV Flush Syringe Market Drivers & Opportunity
  • Table 3. IV Flush Syringe Market Challenges
  • Table 4. IV Flush Syringe Market Restraints
  • Table 5. Global IV Flush Syringe Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global IV Flush Syringe Revenue Market Share by Company (2020-2025)
  • Table 7. Global IV Flush Syringe Sales Volume by Company (2020-2025) & (K Units)
  • Table 8. Global IV Flush Syringe Sales Volume Market Share by Company (2020-2025)
  • Table 9. Global Market IV Flush Syringe Price by Company (2020-2025) & (US$/Unit)
  • Table 10. Key Manufacturers IV Flush Syringe Manufacturing Base and Headquarters
  • Table 11. Key Manufacturers IV Flush Syringe Product Type
  • Table 12. Key Manufacturers Time to Begin Mass Production of IV Flush Syringe
  • Table 13. Global IV Flush Syringe Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IV Flush Syringe as of 2024)
  • Table 15. Mergers & Acquisitions, Expansion Plans
  • Table 16. Global IV Flush Syringe Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 17. Global IV Flush Syringe Sales Value by Type (2020-2025) & (US$ Million)
  • Table 18. Global IV Flush Syringe Sales Value by Type (2026-2031) & (US$ Million)
  • Table 19. Global IV Flush Syringe Sales Market Share in Value by Type (2020-2025)
  • Table 20. Global IV Flush Syringe Sales Market Share in Value by Type (2026-2031)
  • Table 21. Global IV Flush Syringe Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)
  • Table 22. Global IV Flush Syringe Sales Volume by Type (2020-2025) & (K Units)
  • Table 23. Global IV Flush Syringe Sales Volume by Type (2026-2031) & (K Units)
  • Table 24. Global IV Flush Syringe Sales Market Share in Volume by Type (2020-2025)
  • Table 25. Global IV Flush Syringe Sales Market Share in Volume by Type (2026-2031)
  • Table 26. Global IV Flush Syringe Price by Type (2020-2025) & (US$/Unit)
  • Table 27. Global IV Flush Syringe Price by Type (2026-2031) & (US$/Unit)
  • Table 28. Global IV Flush Syringe Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 29. Global IV Flush Syringe Sales Value by Application (2020-2025) & (US$ Million)
  • Table 30. Global IV Flush Syringe Sales Value by Application (2026-2031) & (US$ Million)
  • Table 31. Global IV Flush Syringe Sales Market Share in Value by Application (2020-2025)
  • Table 32. Global IV Flush Syringe Sales Market Share in Value by Application (2026-2031)
  • Table 33. Global IV Flush Syringe Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)
  • Table 34. Global IV Flush Syringe Sales Volume by Application (2020-2025) & (K Units)
  • Table 35. Global IV Flush Syringe Sales Volume by Application (2026-2031) & (K Units)
  • Table 36. Global IV Flush Syringe Sales Market Share in Volume by Application (2020-2025)
  • Table 37. Global IV Flush Syringe Sales Market Share in Volume by Application (2026-2031)
  • Table 38. Global IV Flush Syringe Price by Application (2020-2025) & (US$/Unit)
  • Table 39. Global IV Flush Syringe Price by Application (2026-2031) & (US$/Unit)
  • Table 40. Global IV Flush Syringe Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 41. Global IV Flush Syringe Sales Value by Region (2020-2025) & (US$ Million)
  • Table 42. Global IV Flush Syringe Sales Value by Region (2026-2031) & (US$ Million)
  • Table 43. Global IV Flush Syringe Sales Value by Region (2020-2025) & (%)
  • Table 44. Global IV Flush Syringe Sales Value by Region (2026-2031) & (%)
  • Table 45. Global IV Flush Syringe Sales Volume by Region (K Units): 2020 VS 2024 VS 2031
  • Table 46. Global IV Flush Syringe Sales Volume by Region (2020-2025) & (K Units)
  • Table 47. Global IV Flush Syringe Sales Volume by Region (2026-2031) & (K Units)
  • Table 48. Global IV Flush Syringe Sales Volume by Region (2020-2025) & (%)
  • Table 49. Global IV Flush Syringe Sales Volume by Region (2026-2031) & (%)
  • Table 50. Global IV Flush Syringe Average Price by Region (2020-2025) & (US$/Unit)
  • Table 51. Global IV Flush Syringe Average Price by Region (2026-2031) & (US$/Unit)
  • Table 52. Key Countries/Regions IV Flush Syringe Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 53. Key Countries/Regions IV Flush Syringe Sales Value, (2020-2025) & (US$ Million)
  • Table 54. Key Countries/Regions IV Flush Syringe Sales Value, (2026-2031) & (US$ Million)
  • Table 55. Key Countries/Regions IV Flush Syringe Sales Volume, (2020-2025) & (K Units)
  • Table 56. Key Countries/Regions IV Flush Syringe Sales Volume, (2026-2031) & (K Units)
  • Table 57. BD Company Information
  • Table 58. BD Introduction and Business Overview
  • Table 59. BD IV Flush Syringe Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 60. BD IV Flush Syringe Product Offerings
  • Table 61. BD Recent Development
  • Table 62. Medline Company Information
  • Table 63. Medline Introduction and Business Overview
  • Table 64. Medline IV Flush Syringe Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 65. Medline IV Flush Syringe Product Offerings
  • Table 66. Medline Recent Development
  • Table 67. Medefil Company Information
  • Table 68. Medefil Introduction and Business Overview
  • Table 69. Medefil IV Flush Syringe Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 70. Medefil IV Flush Syringe Product Offerings
  • Table 71. Medefil Recent Development
  • Table 72. B. Braun Company Information
  • Table 73. B. Braun Introduction and Business Overview
  • Table 74. B. Braun IV Flush Syringe Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 75. B. Braun IV Flush Syringe Product Offerings
  • Table 76. B. Braun Recent Development
  • Table 77. Cardinal Health Company Information
  • Table 78. Cardinal Health Introduction and Business Overview
  • Table 79. Cardinal Health IV Flush Syringe Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 80. Cardinal Health IV Flush Syringe Product Offerings
  • Table 81. Cardinal Health Recent Development
  • Table 82. Weigao Group Company Information
  • Table 83. Weigao Group Introduction and Business Overview
  • Table 84. Weigao Group IV Flush Syringe Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 85. Weigao Group IV Flush Syringe Product Offerings
  • Table 86. Weigao Group Recent Development
  • Table 87. Jiangsu Impex Technology Company Information
  • Table 88. Jiangsu Impex Technology Introduction and Business Overview
  • Table 89. Jiangsu Impex Technology IV Flush Syringe Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 90. Jiangsu Impex Technology IV Flush Syringe Product Offerings
  • Table 91. Jiangsu Impex Technology Recent Development
  • Table 92. Fuzhou Haiwang Fuyao Pharmaceutical Co., Ltd. Company Information
  • Table 93. Fuzhou Haiwang Fuyao Pharmaceutical Co., Ltd. Introduction and Business Overview
  • Table 94. Fuzhou Haiwang Fuyao Pharmaceutical Co., Ltd. IV Flush Syringe Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 95. Fuzhou Haiwang Fuyao Pharmaceutical Co., Ltd. IV Flush Syringe Product Offerings
  • Table 96. Fuzhou Haiwang Fuyao Pharmaceutical Co., Ltd. Recent Development
  • Table 97. Shandong Zhongbaokang Company Information
  • Table 98. Shandong Zhongbaokang Introduction and Business Overview
  • Table 99. Shandong Zhongbaokang IV Flush Syringe Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 100. Shandong Zhongbaokang IV Flush Syringe Product Offerings
  • Table 101. Shandong Zhongbaokang Recent Development
  • Table 102. Nam Kwang Chemical Pharmaceuticals Company Information
  • Table 103. Nam Kwang Chemical Pharmaceuticals Introduction and Business Overview
  • Table 104. Nam Kwang Chemical Pharmaceuticals IV Flush Syringe Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 105. Nam Kwang Chemical Pharmaceuticals IV Flush Syringe Product Offerings
  • Table 106. Nam Kwang Chemical Pharmaceuticals Recent Development
  • Table 107. Guangdong Aixide Pharmaceutical Co., Ltd. Company Information
  • Table 108. Guangdong Aixide Pharmaceutical Co., Ltd. Introduction and Business Overview
  • Table 109. Guangdong Aixide Pharmaceutical Co., Ltd. IV Flush Syringe Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 110. Guangdong Aixide Pharmaceutical Co., Ltd. IV Flush Syringe Product Offerings
  • Table 111. Guangdong Aixide Pharmaceutical Co., Ltd. Recent Development
  • Table 112. Guerbet Company Information
  • Table 113. Guerbet Introduction and Business Overview
  • Table 114. Guerbet IV Flush Syringe Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 115. Guerbet IV Flush Syringe Product Offerings
  • Table 116. Guerbet Recent Development
  • Table 117. Sterisets Company Information
  • Table 118. Sterisets Introduction and Business Overview
  • Table 119. Sterisets IV Flush Syringe Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 120. Sterisets IV Flush Syringe Product Offerings
  • Table 121. Sterisets Recent Development
  • Table 122. Aquabiliti Company Information
  • Table 123. Aquabiliti Introduction and Business Overview
  • Table 124. Aquabiliti IV Flush Syringe Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 125. Aquabiliti IV Flush Syringe Product Offerings
  • Table 126. Aquabiliti Recent Development
  • Table 127. Key Raw Materials Lists
  • Table 128. Raw Materials Key Suppliers Lists
  • Table 129. IV Flush Syringe Downstream Customers
  • Table 130. IV Flush Syringe Distributors List
  • Table 131. Research Programs/Design for This Report
  • Table 132. Key Data Information from Secondary Sources
  • Table 133. Key Data Information from Primary Sources

List of Figures

  • Figure 1. IV Flush Syringe Product Picture
  • Figure 2. Global IV Flush Syringe Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global IV Flush Syringe Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Global IV Flush Syringe Sales Volume (2020-2031) & (K Units)
  • Figure 5. Global IV Flush Syringe Sales Price (2020-2031) & (US$/Unit)
  • Figure 6. IV Flush Syringe Report Years Considered
  • Figure 7. Global IV Flush Syringe Players Revenue Ranking (2024) & (US$ Million)
  • Figure 8. Global IV Flush Syringe Players Sales Volume Ranking (2024) & (K Units)
  • Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by IV Flush Syringe Revenue in 2024
  • Figure 10. IV Flush Syringe Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 11. Saline IV Flush Syringe Picture
  • Figure 12. Heparin IV Flush Syringe Picture
  • Figure 13. Global IV Flush Syringe Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 14. Global IV Flush Syringe Sales Value Market Share by Type, 2024 & 2031
  • Figure 15. Global IV Flush Syringe Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)
  • Figure 16. Global IV Flush Syringe Sales Volume Market Share by Type, 2024 & 2031
  • Figure 17. Global IV Flush Syringe Price by Type (2020-2031) & (US$/Unit)
  • Figure 18. Product Picture of Hospital
  • Figure 19. Product Picture of Clinic
  • Figure 20. Product Picture of Others
  • Figure 21. Global IV Flush Syringe Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 22. Global IV Flush Syringe Sales Value Market Share by Application, 2024 & 2031
  • Figure 23. Global IV Flush Syringe Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)
  • Figure 24. Global IV Flush Syringe Sales Volume Market Share by Application, 2024 & 2031
  • Figure 25. Global IV Flush Syringe Price by Application (2020-2031) & (US$/Unit)
  • Figure 26. North America IV Flush Syringe Sales Value (2020-2031) & (US$ Million)
  • Figure 27. North America IV Flush Syringe Sales Value by Country (%), 2024 VS 2031
  • Figure 28. Europe IV Flush Syringe Sales Value, (2020-2031) & (US$ Million)
  • Figure 29. Europe IV Flush Syringe Sales Value by Country (%), 2024 VS 2031
  • Figure 30. Asia Pacific IV Flush Syringe Sales Value, (2020-2031) & (US$ Million)
  • Figure 31. Asia Pacific IV Flush Syringe Sales Value by Region (%), 2024 VS 2031
  • Figure 32. South America IV Flush Syringe Sales Value, (2020-2031) & (US$ Million)
  • Figure 33. South America IV Flush Syringe Sales Value by Country (%), 2024 VS 2031
  • Figure 34. Middle East & Africa IV Flush Syringe Sales Value, (2020-2031) & (US$ Million)
  • Figure 35. Middle East & Africa IV Flush Syringe Sales Value by Country (%), 2024 VS 2031
  • Figure 36. Key Countries/Regions IV Flush Syringe Sales Value (%), (2020-2031)
  • Figure 37. Key Countries/Regions IV Flush Syringe Sales Volume (%), (2020-2031)
  • Figure 38. United States IV Flush Syringe Sales Value, (2020-2031) & (US$ Million)
  • Figure 39. United States IV Flush Syringe Sales Value by Type (%), 2024 VS 2031
  • Figure 40. United States IV Flush Syringe Sales Value by Application (%), 2024 VS 2031
  • Figure 41. Europe IV Flush Syringe Sales Value, (2020-2031) & (US$ Million)
  • Figure 42. Europe IV Flush Syringe Sales Value by Type (%), 2024 VS 2031
  • Figure 43. Europe IV Flush Syringe Sales Value by Application (%), 2024 VS 2031
  • Figure 44. China IV Flush Syringe Sales Value, (2020-2031) & (US$ Million)
  • Figure 45. China IV Flush Syringe Sales Value by Type (%), 2024 VS 2031
  • Figure 46. China IV Flush Syringe Sales Value by Application (%), 2024 VS 2031
  • Figure 47. Japan IV Flush Syringe Sales Value, (2020-2031) & (US$ Million)
  • Figure 48. Japan IV Flush Syringe Sales Value by Type (%), 2024 VS 2031
  • Figure 49. Japan IV Flush Syringe Sales Value by Application (%), 2024 VS 2031
  • Figure 50. South Korea IV Flush Syringe Sales Value, (2020-2031) & (US$ Million)
  • Figure 51. South Korea IV Flush Syringe Sales Value by Type (%), 2024 VS 2031
  • Figure 52. South Korea IV Flush Syringe Sales Value by Application (%), 2024 VS 2031
  • Figure 53. Southeast Asia IV Flush Syringe Sales Value, (2020-2031) & (US$ Million)
  • Figure 54. Southeast Asia IV Flush Syringe Sales Value by Type (%), 2024 VS 2031
  • Figure 55. Southeast Asia IV Flush Syringe Sales Value by Application (%), 2024 VS 2031
  • Figure 56. India IV Flush Syringe Sales Value, (2020-2031) & (US$ Million)
  • Figure 57. India IV Flush Syringe Sales Value by Type (%), 2024 VS 2031
  • Figure 58. India IV Flush Syringe Sales Value by Application (%), 2024 VS 2031
  • Figure 59. IV Flush Syringe Industrial Chain
  • Figure 60. IV Flush Syringe Manufacturing Cost Structure
  • Figure 61. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 62. Bottom-up and Top-down Approaches for This Report
  • Figure 63. Data Triangulation
  • Figure 64. Key Executives Interviewed